Evidence map›Paper›PMID 39920816›Full record

ArticleJournal of orthopaedic surgery and research2025

Evaluation and testing of polymethylmetacrylic (PMMA) bone cements with admixed Amphotericin B.

Florian A Frank, Barbara Krampitz, Julia Steiner, Rainer Strathausen, Mario Morgenstern, Martin Clauss, Klaus-Dieter Kühn

Erratum issuedAbstract readCase Reports
In one paragraph

Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Brazilian guidelines for the diagnosis and treatment of candidemia and invasive candidiasis in adults and children.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Guideline
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Florian A FrankCentre for Musculoskeletal Infections (ZMSI), University Hospital of Basel, Basel, 4031, Switzerland. florian.frank@t-online.de.
Barbara KrampitzHeraeus Medical, Philipp-Reis-Strasse 8-13, 61273, Wehrheim, Germany.
Julia SteinerDepartment of Orthopaedics and Traumatology, Medical University of Graz, Graz, 8036, Austria.
Rainer StrathausenHeraeus Medical, Philipp-Reis-Strasse 8-13, 61273, Wehrheim, Germany.
Mario MorgensternCentre for Musculoskeletal Infections (ZMSI), University Hospital of Basel, Basel, 4031, Switzerland.
Martin ClaussCentre for Musculoskeletal Infections (ZMSI), University Hospital of Basel, Basel, 4031, Switzerland.
Klaus-Dieter KühnDepartment of Orthopaedics and Traumatology, Medical University of Graz, Graz, 8036, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAmphotericin is admixed to Polymethylmethacrylic (PMMA) spacers for fungal periprosthetic joint infections (PJI) during two-stage exchanges. We aimed to analyse the mechanical properties of PMMA cement with admixed Amphotericin B. MATERIALS AND

methodsWe tested Amphotericin in PMMA cement mechanically, its elution properties in vitro and present two cases of fungal PJI treated with Amphotericin B powder in Copal cement in vivo.

resultsSterile Amphotericin B is not available as a pure substance but only as powder for infusions. PMMA mixed with such pharmaceutical Amphotericin B formulations colored the cement orange. Compression strength was slightly decreased, bending and impact strength significantly decreased whereas bending modulus was increased. Drug elution was high within the first 24 h and decreased over time until day 5. Amphotericin B in combination with Copal was successfully used in two cases with Candida ssp. INFECTIONS: No negative side effects, especially no nephrotoxic effects, were observed. Sterile Amphotericin B powder for preparing an infusion solution contains only small amounts of pure drug. In vivo polymicrobial Candida-infections with bacterial co-infection were successfully treated using the combination of Copal cements with added Amphotericin B without systemic nephrotoxic impact.

conclusionsThe addition of Amphotericin B to PMMA cement affects the cement's properties in vitro whereas in vivo the combination with Copal is clinically successful in treating complex cases of fungal PJI. LEVEL OF EVIDENCE: Level IV.

Indexed as

Amphotericin BAntifungal AgentsBone CementsMaterials TestingPolymethyl MethacrylateProsthesis-Related InfectionsAgedCandidiasisFemaleHumansMaleMiddle AgedAmphotericin BAntifungal AgentsBone CementsPolymethyl MethacrylateAmphotericin BCandidaFungal PJIISO 5833PMMA

Identifiers

PMID39920816
PMCPMC11806800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.